Filling the need for trusted information on national health issues…

Trending on kff Medicare & Medicaid at 50 Individual Market Medicaid Expansion

  • your selections
Clear Search

Filter Results




Content Type

  • results
  • state & global data
  • slides
Variations in State Medicaid Buy-in Practices for Low-Income Medicare Beneficiaries: A 1999 Update

This report updates a 1997 Foundation report to assess how states are implementing financial protections for the 16 million Medicare beneficiaries who are low-income. These protections, generally referred to as “buy-in programs,” help low-income Medicare beneficiaries meet Medicare's cost-sharing requirements by using state Medicaid programs to pay either all or…

Targeting Medicare Drug Benefits: Costs and Issues

This report, written by Marilyn Moon and Matthew Storeygard of the Urban Institute, estimates the potential cost of targeting drug benefits to low-income Medicare beneficiaries and those with catastrophic drug expenses and discusses some of the key programmatic issues that could arise under this approach. The authors predict that a…

The Future of Retiree Health Benefits: Challenges and Options

Tricia Neuman, Vice President and Director of the Medicare Policy Project testified before the House Subcommittee on Employer-Employee Relations on retiree health coverage for older Americans. The statement describes the health needs of aging adults and the importance of health insurance coverage at a time in their lives when they…

Private Long-Term Care Insurance:  Who Should Buy It and What Should They Buy?

Private Long-Term Care Insurance: Who Should Buy It and What Should They Buy?Despite the growing interest in private long-term care insurance (LTCI), there has been little independent examination of how much protection LTCI policies provide consumers or whether LTCI policies are a worthwhile purchase for people of average means. This…

Views of the New Medicare Drug Law – Chartpack By Income Group

This comprehensive survey of people on Medicare, conducted in June and July 2004, assesses their attitudes toward the new Medicare drug law. This chartpack, issued in September 2004, presents additional analysis on the survey data, looking at key findings broken down by income group.Chartpack (.pdf)

Prescription Drug Spending Under The MMA: Modeling The Impact On Out-of-Pocket Costs

This report projects the impact of the new Medicare drug benefit on out-of-pocket spending for people who enroll in 2006. The analysis is based on a model developed by the Actuarial Research Corporation for the Kaiser Family Foundation. The model generally conforms to the Congressional Budget Office’s assumptions and projections…

Medicare Part D 2009 Data Spotlight: The Coverage Gap

This Medicare Part D data spotlight examines the coverage gap, or “doughnut hole,” in Medicare drug plans available in 2009. While in the gap in coverage, Part D enrollees (other than those receiving low-income subsidies) are required to pay 100 percent of total drug costs until they reach the catastrophic…